Twice-a-day insulin glargine mixed with rapid-acting insulin analogs versus standard neutral protamine Hagedorn therapy for newly diagnosed type 1 diabetes

被引：0
|
作者：
Al Shamsi, Aisha Mohammed [1 ]
机构：
[1] UAE Univ, Fac Med & Hlth Sci, Dept Pediat, Al Ain 9715, U Arab Emirates
来源：
PEDIATRICS | 2008年 / 122卷 / 03期
关键词：
D O I：
10.1542/peds.2008-1636
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
引用
收藏
页码：675 / 676
页数：8
相关论文
共 50 条
  • [1] Twice-a-day insulin glargine mixed with rapid-acting insulin analogs versus standard neutral protamine Hagedorn therapy for newly diagnosed type 1 diabetes - Reply
    Hassan, Krishna V.
    [J]. PEDIATRICS, 2008, 122 (03) : 676 - 676
  • [2] A randomized, controlled trial comparing twice-a-day insulin glargine mixed with rapid-acting insulin analogs versus standard neutral protamine Hagedorn (NPH) therapy in newly diagnosed type 1 diabetes
    Hassan, Krishnavathana
    Rodriguez, Luisa M.
    Johnson, Susan E.
    Tadlock, Susanne
    Heptulla, Rubina A.
    [J]. PEDIATRICS, 2008, 121 (03) : E466 - E472
  • [3] Insulin Glargine versus Neutral Protamine Hagedorn Insulin for Treatment of Diabetes in Pregnancy
    Smith, Jennifer G.
    Manuck, Tracy A.
    White, Jenifer
    Merrill, David C.
    [J]. AMERICAN JOURNAL OF PERINATOLOGY, 2009, 26 (01) : 57 - 62
  • [4] Regular insulin is as effective as rapid-acting insulin analogs in combination with glargine insulin in type 1 diabetic patients
    Ampudia-Blasco, FJ
    Girbés, J
    Sanz, J
    Pedro, T
    Martínez, S
    Catalá, M
    Carmena, R
    [J]. DIABETOLOGIA, 2005, 48 : A92 - A92
  • [5] Mixing rapid-acting insulin analogues with insulin glargine in children with type 1 diabetes mellitus
    Fiallo-Scharer, Rosanna
    Horner, Brian
    McFann, Kim
    Walravens, Philippe
    Chase, H. Peter
    [J]. JOURNAL OF PEDIATRICS, 2006, 148 (04): : 481 - 484
  • [6] Basal insulin analogs versus neutral protamine hagedorn for type 2 diabetics
    Bartal, Michal Fishel
    Ward, Clara
    Refuerzo, Jerrie S.
    Ashimi, Sunbola S.
    Joycelyn, Cornthwaite A.
    Chen, Han-Yang
    Chauhan, Suneet P.
    Sibai, Baha M.
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2019, 220 (01) : S273 - S274
  • [7] Basal Insulin Analogs versus Neutral Protamine Hagedorn for Type 2 Diabetics
    Fishel Bartal, Michal
    Ward, Clara
    Refuerzo, Jerrie S.
    Ashimi, Sunbola S.
    Joycelyn, Cornthwaite A.
    Chen, Han-Yang
    Chauhan, Suneet P.
    Sibai, Baha M.
    [J]. AMERICAN JOURNAL OF PERINATOLOGY, 2020, 37 (01) : 30 - 36
  • [8] Long-Term Cost-Effectiveness of Insulin Glargine Versus Neutral Protamine Hagedorn Insulin for Type 2 Diabetes in Thailand
    Permsuwan, Unchalee
    Chaiyakunapruk, Nathorn
    Dilokthornsakul, Piyameth
    Thavorn, Kednapa
    Saokaew, Surasak
    [J]. APPLIED HEALTH ECONOMICS AND HEALTH POLICY, 2016, 14 (03) : 281 - 292
  • [9] Long-Term Cost-Effectiveness of Insulin Glargine Versus Neutral Protamine Hagedorn Insulin for Type 2 Diabetes in Thailand
    Unchalee Permsuwan
    Nathorn Chaiyakunapruk
    Piyameth Dilokthornsakul
    Kednapa Thavorn
    Surasak Saokaew
    [J]. Applied Health Economics and Health Policy, 2016, 14 : 281 - 292
  • [10] Long-acting insulin analogs versus neutral protamine hagedorn insulin and the risk of severe hypoglycemia among patients in type 2 diabetes in the United Kingdom
    Brunetti, Vanessa C.
    Filion, Kristian
    Yu, Oriana Hoi Yun
    Platt, Robert
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 114 - 114
12345